D.M. Lambert

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

Patrice D. Cani, Sam Possemiers, Tom Van de Wiele et al. · Gut · 2009 · 2.5K citations · Full text

Life Sciences, Immunology, Microbiology +17

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.

D.M. Lambert, Shawn Barney, Anick Lambert et al. · Proceedings of the National Academy of Sciences · 1996 · 333 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.

T K Hart, Richard Kirsh, Harma Ellens et al. · Proceedings of the National Academy of Sciences · 1991 · 206 citations

Life Sciences, Infectious Diseases, Molecular Biology +15

Impact of Human Immunodeficiency Virus Type 1 gp41 Amino Acid Substitutions Selected during Enfuvirtide Treatment on gp41 Binding and Antiviral Potency of Enfuvirtide In Vitro

Mike Mink, Sarah Mosier, S. Janumpalli et al. · Journal of Virology · 2005 · 129 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells

D.M. Lambert, Stephen R. Petteway, C E McDanal et al. · Antimicrobial Agents and Chemotherapy · 1992 · 66 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17